Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HETERO DRUGS LIMITED

Home Clinical Trial Sponsors and OrganizationsHETERO DRUGS LIMITED

HETERO DRUGS LIMITED

8-3-166/7/1, Hyderabad, Telangana, India

Also known as:

hetro

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

14

0 active

Approvals

2

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

8

57.1%

Phase 4

4

28.6%

Phase 1

2

14.3%

Trial Status Distribution

Completed

14

100.0%

Clinical Trials

Trials sponsored by this organization (14)

Post marketing study to assess side effects, antibody development and effectiveness of Hetero-Rituximab

Mar 2018200 participants

A clinical study to evaluate the Pharmacokinetic and Pharmacodynamic properties of Darbepoetin alfa Injection, Hetero and â€˜ARANESPÂ®â€™ (Darbepoetin alfa Injection, Amgen), in Healthy Adult Human Subjects

Nov 201648 participants

Post-marketing SurveillanceStudy in patients prescribed with Darbepoetin alfa

Jun 2016500 participants

A clinical study to evaluate the efficacy, safety, immunogenicity, and pharmacokinetics of subcutaneous injection of Adalimumab (Test Product, Hetero) and Reference Medicinal Product (Reference product, AbbVie) concomitantly administered with Methotrexate in patients with Rheumatoid Arthritis

Apr 2016120 participants

A clinical trial to study the effects of Bevacizumab injection (Hetero) against Reference Medicinal Product (Reference product, Roche) in patients suffering from metastatic colorectal cancer

Dec 2015111 participants

A clinical trial to study the effects of Rituximab injection (Hetero) in Indian patients suffering from varieties of Non-Hodgkins Lymphoma.

Aug 2013150 participants

A clinical trial to study the effects of Darbepoetin alfa in the treatment of anemia caused by chronic kidney disease.

Jan 2012236 participants

A clinical trial to study the effects of Bevacizumab injection (Hetero) against Reference Medicinal Product (Reference product, Roche) in patients suffering from metastatic colorectal cancer

137 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

2

Approvals

Recent Approvals

Lithium Carbonate

Lithium Carbonate

News

No news articles found

On this page

Overview
Clinical Trials14
Approvals2
News

Back to Organizations